INFECTECH INC
10SB12G/A, EX-27, 2000-12-13
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: INFECTECH INC, 10SB12G/A, 2000-12-13
Next: NEOMAGIC CORP, 10-Q, 2000-12-13



<TABLE> <S> <C>

<ARTICLE>   5

<S>                                                                   <C>
<PERIOD-TYPE>                                                        9-MOS
<FISCAL-YEAR-END>                                                 DEC-31-1999
<PERIOD-END>                                                      SEP-30-1999
<CASH>                                                                 81,466
<SECURITIES>                                                                0
<RECEIVABLES>                                                               0
<ALLOWANCES>                                                                0
<INVENTORY>                                                                 0
<CURRENT-ASSETS>                                                       81,757
<PP&E>                                                                 45,967
<DEPRECIATION>                                                         20,872
<TOTAL-ASSETS>                                                        658,375
<CURRENT-LIABILITIES>                                                  33,793
<BONDS>                                                                     0
<COMMON>                                                              129,616
                                                       0
                                                                 0
<OTHER-SE>                                                            494,966
<TOTAL-LIABILITY-AND-EQUITY>                                          658,375
<SALES>                                                                 7,290
<TOTAL-REVENUES>                                                        7,290
<CGS>                                                                       0
<TOTAL-COSTS>                                                               0
<OTHER-EXPENSES>                                                      421,250
<LOSS-PROVISION>                                                            0
<INTEREST-EXPENSE>                                                          0
<INCOME-PRETAX>                                                      (413,960)
<INCOME-TAX>                                                                0
<INCOME-CONTINUING>                                                  (413,960)
<DISCONTINUED>                                                              0
<EXTRAORDINARY>                                                             0
<CHANGES>                                                                   0
<NET-INCOME>                                                         (413,960)
<EPS-BASIC>                                                           (.06)
<EPS-DILUTED>                                                           (.06)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission